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ABSTRACT 
 
Background: Incidence of subclinical hypothyroidism is 2.3% of pregnancies and overt hypothyroidism being 
0.2%.Further incidence of hypertension one of the complications of maternal hypothyroidism strongly correlates 
with the levels of serum thyroid stimulating hormone (TSH). This study is designed to study maternal and fetal 
outcome in hypothyroid normotensive pregnancies (group 1) and hypothyroid hypertensive pregnancies (group 2) 
and to study the severity of hypertension in relation to thyroid function levels.Methodology: The prospective study 
was conducted on antenatal mothers attending MGMH,Petlaburz,OsmaniaMedicalCollege,Hyderabad during the 
period November 2012 to May 2014.The study was based on the analyses of 50 pregnant mothers diagnosed to have 
hypothyroidism .These included cases diagnosed before as well as during pregnancy .Another 50 pregnant mothers 
diagnosed to have hypothyroidism and developed hypertension during the course of pregnancy. Follow up was done 
with serum TSH and free T4 levels throughout pregnancy and outcomes were studied. Trimester specific values for 
thyroid function tests are used. Results: Cases suffering from overt hypothyroidism were 50% in group2 compared 
to 30% in group1 (chi-square=5.997, p value=0.04986).GHTN was seen in 52% of group 2 patients of which 12% 
belong to overt hypothyroid group. On the other hand 42% suffered from preeclampsia of which 32% belong to 
overt group (chi-square=16.55,p value=0.00236). A change in dosage was required in 36% in group1 & 42% in 
group2.  Complications - preterm (grp1 4% & grp2 10%), IUD (grp1 2% & grp2 10%), IUGR (grp1 6% & grp2 
14%) and Abruption (grp1 2% & grp2 6%) were observed. Conclusion: Changes in the thyroid hormone levels 
might be correlated with occurrence and severity of pre-eclampsia. 
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Introduction 
 
 
Incidence of subclinical hypothyroidism (elevated 
serum thyroid stimulating hormone (TSH) and 
normal freeT4) is 2.3% of pregnancies and overt 
hypothyroidism (elevated TSH and reduced free T4) 
being 0.2% of pregnancies. Maternal hypothyroidism 
is the most common disorder of thyroid function in 
pregnancy and has been associated with miscarriage, 
fetal loss ,preeclampsia ,preterm delivery ,placental 
abruption ,low birth weight ,fetal distress and reduced 
intellectual function of the offspring[1-4]. 
_______________________________ 
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Mechanism of association between hypothyroid and 
preeclampsia is not well understood but the proposed 
mechanisms are- due to modest decrease in thyroid 
hormones with concomitant increase in S.TSH in 
maternal serum correlated with severity of 
preeclampsia/eclampsia and high levels of 
endothelin, Nitric Oxide (NO) a vasodilator released 
from endothelial cells regulates secretion of thyroid 
hormones by modulating regional blood flow in an 
animal study[5], the faulty estrogen production due to 
placental dysfunction reduces concentration of 
thyroid binding globulin, T4&T3 in preeclampsia 
women[6].Up to 20% of biochemically hypothyroid 
women are asymptomatic. A high index of suspicion 
is required in women treated previously for 
hypothyroidism, those with previous head and neck 
irradiation, previous postpartum thyroiditis and those 
with goiter and on drug therapies with side effects on 
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thyroid gland[7].The likelihood that either maternal 
or fetal complication will arise depends on the 
severity of disease and adequacy of treatment. 
Gestational hypertension occurs more often in overtly 
hypothyroid women (36%) than in women with 
subclinical disease (25%) or the general 
population(8%)[8].A separate study reported a 
markedly increased use of caesarian section because 
of fetal distress among women who were severely 
hypothyroid(56%) at their initial antenatal visit 
compared with women who were mildly hypothyroid 
or euthyroid(3%)[9].Research has shown that the 
incidence of low birth weight neonates is markedly 
increased in cases of overt hypothyroid (22%) 
compared with subclinical disease (9%) and the 
general population (7%)[8].Thyroxin requirements 
increase by 50-100% in the first trimester and is 
sustained throughout pregnancy. The present study 
aims at the study of maternal and fetal outcome in 
hypothyroid normotensive patients and hypothyroid 
patients associated with hypertension, need for dose 
adjustment and to study the severity of hypertension 
in hypothyroid patients.
 
 
Methodology 
This is a prospective cohort study conducted in a 
tertiary care referral center during the period 
November 2012 –May 2014 after obtaining clearance 
from institutional ethical committee of Osmania 
Medical College, Hyderabad.  Pregnant women 
diagnosed to have hypothyroidism (known cases of 
hypothyroid or diagnosed during pregnancy) and 
developed hypertension (Gestational hypertension, 
preeclampsia & eclampsia) during the course of 
pregnancy have been selected as cases. Mothers 
suffering from hypothyroidism attending antenatal 
out-patients with blood pressure values in normal 
range and willing to participate in the study were 
selected as controls. These Included cases diagnosed 
before pregnancy as well as during pregnancy. A 
written informed consent was taken from both cases 
and controls. With 30% of pregnancies to have 
desired outcome in control group with 95% 
confidence interval and an allowable error of 20% 
and to estimate a relative risk of two, the estimated 
sample size is calculated at 42 in each group and a 
total of 50 per group were recruited and studied. A 
detailed history was taken regarding clinical 
symptoms of hypothyroidism, obstetric history, past 
medical history about drugs affecting thyroid, family 
history and personal history. A thorough general 
physical examination with reference to temperature, 
pulse rate(PR),blood pressure(BP),respiratory 
rate(RR) followed by systemic examination of 
Cardiovascular system(CVS), Central nervous 
system(CNS) , Respiratory System(RS)  and local 
thyroid examination. All patients were sent for 
S.TSH testing. If S.TSH levels are deranged 
FT4&FT3 levels are checked. Trimester specific 
values for thyroid function test were taken [10]. 
Those with TSH>2.3micU/ml,FT3<1.9pg/ml 
andFT4<0.86ng/dl are classified as overt 
hypothyroid. Patients with TSH>2.3 micU/ml, FT3 
and FT4 within reference ranges were classified as 
subclinical hypothyroid. If S.TSH, FT3, &FT4 are in 
normal range considered euthyroid. Diagnosis is 
based on symptoms, clinical signs and biochemistry 
levels. Cases of Chronic hypertension, Endocrine & 
medical disorder affecting thyroid, medications 
affecting thyroid and renal diseases are excluded. 
Levothyroxine is the standard mode of management 
given. Initial dose depends on the severity. If S.TSH 
is <10micIU/ml, L-throxine dosage starting with 
0.10mg/d is sufficient. Therapy increased by 0.25 to 
0.50mg/day every 2-4wkly intervals till euthyroid 
status is obtained. Main aim is to maintain thyroid 
function tests in normal range. Follow up was done 
with S.TSH&FT4 measurements. Frequency of 
testing during pregnancy varied depending on 
control. TFTs repeated every 3-4wks in first half of 
pregnancy and 6-8wkly in the second half of 
pregnancy if not under control. If thyroid status is 
under control repeated each trimester. Further all 
patients were seen by endocrinologist for dosage 
adjustment. Progression of thyroid disorder, 
hypertension and complications arising from them 
like preterm deliveries, intrauterine fetal death, 
intrauterine growth restriction, gestational diabetes 
mellitus and abruption were studied. 
Descriptive statistics like frequencies and percentages 
were used to express baseline characteristics of study 
population. MS-excel were used for all statistical 
analysis. 
 
 
 
 
 
 
 
Asian Pac. J. Health Sci., 2017; 4(3):182-190                                            e-ISSN: 2349-0659,   p-ISSN: 2350-0964                         
____________________________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________________________ 
Sravani and Ramaiah               ASIAN PACIFIC JOURNAL OF HEALTH SCIENCES, 2017; 4(3):182-190 
www.apjhs.com                184 
 
Results & analysis 
Table 1:  Baseline characteristic of study population Age distribution, gravida, period of hypothyroid 
diagnosis 
 Group I (cases) n (%) Group II (Controls) n (%)  Total  
Age group    
18-20 years 05   (10) 06  (12) 11  
21-25 years 28  (56) 33  (66) 61 
26-30 years 16  (32) 11  (22) 27 
31-35 years 01  (02) 00  (00) 01 
Gravidity    
Primi 21 (42) 26 (52) 47 
second 18 (36) 12 (24) 30 
Third  06 (12) 08 (16) 14 
Fourth 04 (08) 04 (08) 08 
Fifth  00 (00) 00 (00) 00 
sixth 01 (02) 00 (00) 01 
Period of diagnosis    
Pre pregnancy 24 (48) 25 (50) 49 
During pregnancy 26 (52) 25 (50) 51 
  
Group 1 –hypothyroid normotensive patients 
Group2–hypothyroid hypertensive patients 
 
Fig 1: In the present study age distribution ranged from 18-35yrs. 
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Fig 2:Majority of the patients in both the groups  were primigravida (group1 -42% & group2 -52%) and 
constitute 47% of the total cases 
 
 
Fig 3 :49%  of total cases were diagnosed during pregnancy for the first time 
51% of cases were already known cases of  hypothyroid diagnosed before pregnancy 
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Table 2:Hypothyroid status at the time of diagnosis
Chi square=5.997 ,P value=0.04986 
Overall 40% of the patients belong to overt group,35% subclinical & 25% maintained euthyroid status. 
In group 1 –majority about 46% of cases were subclinical, 30% overt  & 24% euthyroid 
In group2-50% of cases were overt ,26% euthyroid  & 24% subclinical cases 
 
 
Table 3:Distribution of hypertension in hypothroid patients(group 2) 
 
Thyroid 
status 
GHTN    %   PE    % APE    % TOTAL     % 
Euthyroid   11   22    2    4    0    0    13   26 
Subclinical    9   18    3    6    0    0    12   24 
Overt    6   12   16   32    3    6    25   50 
TOTAL   26   52   21   42    3    6    50 100 
Chi square=16.55 ,Pvalue=0.002365 
GHTN-gestational hypertension,PE-preeclampsia,APE-antepartum eclampsia 
Incidence of GHTN is 52% (22%-euthyroid,18%subclinical,12%overt hypothyroid) PE is 
42%(4%euthyroid,6%subclinical,32% overt  hypothyroid) & APE is 6% (overt hypothyroidism) 32% of the 
preeclampsia patients were suffering from overt hypothyroidism 
Dosage change during pregnancy 
Table 4:Group 1 
Period of diagnosis change in dose      % No change      % 
Pre preg     13    26     12     24 
 preg      5    10     17     34 
TOTAL    18    36     29     58 
Treatment not taken by 3(6%) patients 
Dosage change is seen in 36% patients at any time during pregnancy. 
No change in 58% patients. 
Table 5:Group2 
Period of diagnosis Change in dose      % No change       % 
Pre preg      12     24     13     26 
Preg      9     18     16     32 
TOTAL      21     42     29     58 
 
Change in dosage is seen in 42% patients of which 24% were already known cases hypothyroid diagnosed before 
pregnancy.No change in 58% patients. 
 Group 1 Group 2 Total 
Thyroid 
status 
No % No % No % 
Euthyroid 12 24 13 26 25 25 
Sub clinical 23 46 12 24 35 35 
Overt 15 30 25 50 40 40 
TOTAL 50 100 50 100 100 100 
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Fig 4 :IUD- intra uterine death ,GDM- gestational diabetes mellitus ,IUGR- intra uterine growth restriction 
Group 1-preterm 4%,IUD 2%,GDM 4%,IUGR 6% & Abruption 2% . 
Group 2-preterm 10%,IUD 10%,GDM 4%,IUGR 14% & Abruption 6%. 
 
Fig 5 :Group1– total LSCS-24(48%) :Emergency -12(24%)& Elective -12(24%) 
Group2- total LSCS-27(54%):Emergency-17(34%) & Elective -9(18%)  Em.hysterotomy-1(2%) for abruption 
patient 
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Discussion 
Thyroid dysfunction has an adverse effect on maternal 
and fetal wellbeing. Uncontrolled hypothyroidism and 
subtle hypothyroxinemia can cause adverse effect on 
obstetric and fetal outcome & also neuro-intellectual 
development in the offspring. In the present study 
maternal and fetal outcomes in hypothyroid 
normotensive patients (group1) and hypothyroid 
patients with associated hypertension (group2) were 
studied. In the present study 61% of the total patients 
were in the age group of 21-25yrs and 47% of the total 
patients were primigravida. No significant differences 
were seen in age and gravidity in both the groups. 
Cases suffering from overt hypothyroidism were 50% 
in group 2 compared to 30% in group1 (chi-
square=5.997, p value=0.04986). Gestational 
hypertension (GHTN) was seen in 52% of group2 
patients of which 12% belong to overt hypothyroid 
group. On the other hand 42% belong to preeclampsia 
of which 32% belong to overt group (chi-square=16.55, 
p value=0.00236).Although pregnancy is associated 
with mild hyperthyroxinemia, preeclampsia women 
have higher incidence of hypothyroidism[6].A study by 
Nadia et al[11]has shown a strong relationship between 
preeclampsia and hypothyroidism as 56% of screened 
preeclampsia patients had hypothyroidism. On the 
other hand preeclampsia is observed in 16.7% of 
subclinical and 43.7% of overt hypothyroid 
cases[12].BasbunG[15] studied that moderate decrease 
in thyroid hormones with concomitant increase in 
S.TSH levels correlate with severity of preeclampsia 
with a significant increase in endothelin levels  
.S.TSH(1.55+/0.89microIU/mLversus2.96+/1.07micro
IU/mL,P<.05)andendothelin(2.31+/0.61pg/mLversus6.
11+/1.41pg/mL,P<.001). Kumar.A[13]had showed that 
approximately 40% of preeclampsia women had 
S.TSH>5miu/ml compared to 12.2% in control. Leung 
et al[8] studied that 36% of overt and 25% of 
subclinical cases who remained hypothyroid at delivery 
developed hypertension. In this study 49% of 
hypothyroid cases were diagnosed during pregnancy & 
51% were already known cases of hypothyroid 
diagnosed before pregnancy. Further a change in 
dosage requirement is seen in 36% in group1& 42% in 
group2.A retrospective study by Mandel SJ[14]had 
showed an increase in thyroxin requirement in 9 of 12 
patients. Another study has showed an increase in 
thyroid requirement in 60% of patients at any time 
during pregnancy[15].Most of the cases in the present 
study had their visit in the 2
nd
 trimester when already 
changes in thyroid physiology have taken place and the 
need for thyroid dose change is decreased. 
Complications seen in the present study were preterm 
(grp1 4% & grp2 10%), IUD (grp1 2% & grp2 10%), 
IUGR (grp1 6% & grp2 14%) and Abruption (grp1 2% 
& grp 2 6), Gestational Diabetes Mellitus (grp1&2 
4%). Not much difference in GDM is seen in both the 
groups. But a higher incidence of preterm, IUD, IUGR 
and abruption is seen in group2.This is secondary to 
the severity of preeclampsia associated with raised 
thyrotropin levels similar to a study by Kumar.A 
[13]which showed approximately 40% of preeclampsia 
women had S.TSH>5miu/ml compared to 12.2% in 
control. IUGR& abruption complications were similar 
to a study by Goeletal et al[16] and IUD rates were 
comparable to a study by Davis[12] in overt 
hypothyroid patients. Tudela[18]studied that risk of 
developing GDM increases with increased thyrotropin 
levels. A negative correlation observed between birth 
weight and S.TSH in preeclampsia(r=-0.296, p<0.001) 
M.Abolovich[19] studied that abortion, preterm & term 
deliveries in patients who are euthyroid on 
levothyroxine at the time of conception were 4%, 11%, 
and 84.9% respectively. Another study had showed that 
risk of preterm increase by two fold and  risk of 
abruption by three times in subclinical hypothyroid 
patients[20].Ashoor[21]studied impaired thyroid 
function may predispose to miscarriage and fetal death. 
Wassurtrum [9] studied that 56% of pregnancies which 
initially presented with severe hypothyroidism resulted 
in caesarian section for fetal distress compared to 3% 
in mild hypothyroid/euthyroid patients. Study by 
R.Tudosa et al[22]showed early administration of 
treatment and maintenance of euthyroid status 
minimizes the risk of maternal and fetal complications. 
Exact mechanism whereby preterm labour, placental 
abruption and other pregnancy related complications 
occur is not known but one hypothesis being faulty 
early placentation.        
Conclusion & summary 
Thyroid hormone is essential for normal placental 
function and fetal brain development which in first 
trimester is dependent entirely on maternal thyroid 
hormone. Thyroid dysfunction has an adverse effect on 
maternal and fetal outcome. Of the total number of 
cases 61% were in the age group of 21-25 and 47% 
were primigravida. In group1 46% were suffering from 
subclinical and 30% from overt hypothyroidism 
whereas in group2 50% were suffering from overt and 
24% from subclinical hypothyroidism. Of the 50% of 
the overt group with hypertension 32% were associated 
with preeclampsia. Changes in the thyroid hormone 
levels might be correlated with occurrence and severity 
of preeclampsia[13]. Further identification of thyroid 
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hormone in pregnancy might be of help in predicting 
preeclampsia[23].Need for thyroid dosage adjustment 
was 36% in group1 and 42% in group2.Thyroxine 
dosage often needs to be increased by 30%-50% by 4-6 
weeks[Endocrine society, 2007].But most of the 
patients in our study had their first visit in second 
trimester when already changes in thyroid physiology 
has taken place. Complications in group2 (preterm-
10%, IUD-10%, GDM-4%, LBW-14%, abruption-6%) 
were slightly higher than in group1 (preterm-4%, IUD-
2%, GDM-4%, LBW-6%, abruption 2%) due to the 
severity of preeclampsia associated in group2. Early 
intervention with levo thyroxin showed no adverse 
obstetric and perinatal outcome[22].Hence 
preconception and early pregnancy counseling 
regarding importance of thyroid control is 
recommended. Currently the need for universal thyroid 
screening is controversial. Targeted screening can 
detect only two thirds of the cases[24] and also 
universal screening is found to be more cost effective 
than not screening[25].As early diagnosis and thyroxin 
replacement can prevent the adverse maternal and 
perinatal complications, thyroid function tests should 
be included in the line of routine investigations done on 
antenatal mothers. 
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